Sales rise 18.88% to Rs 164.26 crore
Net profit of Astrazeneca Pharma India rose 3322.50% to Rs 27.38 crore in the quarter ended September 2017 as against Rs 0.80 crore during the previous quarter ended September 2016. Sales rose 18.88% to Rs 164.26 crore in the quarter ended September 2017 as against Rs 138.17 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales164.26138.17 19 OPM %21.702.29 -PBDT38.145.05 655 PBT34.390.99 3374 NP27.380.80 3323Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
